Development and internal validation of a Viremia-Integrated Risk Assessment (VIRA score) for predicting mortality at diagnosis of COVID-19 pneumonia
Sonsoles Salto-Alejandre, Cristina Rodríguez-Urbistondo, Javier Martín‐Escolano, Ana Ruiz-Molina et autres
BACKGROUND: CURB-65 score usefulness has been assessed in COVID-19 pneumonia, but not in cohorts including immunocompromised patients. SARS-CoV-2 RNAemia is associated with mortality and unfavorable clinical outcomes in COVID-19. This study aimed to develop the VIRA score (Viremia-Integrated Risk Assessment), incorporating CURB-65 …
es (code pays fourni par la source)